Short Interest in Maximus, Inc. (NYSE:MMS) Increases By 22.1%

Maximus, Inc. (NYSE:MMS) was the target of a large increase in short interest in August. As of August 15th, there was short interest totalling 725,300 shares, an increase of 22.1% from the July 31st total of 593,800 shares. Based on an average trading volume of 375,100 shares, the days-to-cover ratio is currently 1.9 days. Currently, 1.2% of the company’s stock are short sold.

Institutional Investors Weigh In On Maximus

A number of institutional investors have recently made changes to their positions in the company. New York State Common Retirement Fund boosted its stake in Maximus by 31.5% during the 4th quarter. New York State Common Retirement Fund now owns 31,898 shares of the health services provider’s stock valued at $2,675,000 after purchasing an additional 7,641 shares during the last quarter. Retirement Systems of Alabama boosted its position in shares of Maximus by 0.3% during the fourth quarter. Retirement Systems of Alabama now owns 76,128 shares of the health services provider’s stock valued at $6,384,000 after buying an additional 232 shares during the last quarter. Los Angeles Capital Management LLC increased its holdings in Maximus by 24.2% in the 4th quarter. Los Angeles Capital Management LLC now owns 6,425 shares of the health services provider’s stock worth $539,000 after buying an additional 1,250 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in Maximus by 1.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 716,501 shares of the health services provider’s stock worth $60,086,000 after buying an additional 8,702 shares during the last quarter. Finally, Wealthspire Advisors LLC bought a new position in Maximus during the 4th quarter valued at about $1,506,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Stock Down 0.2 %

Maximus stock traded down $0.15 on Friday, hitting $92.26. 490,574 shares of the stock traded hands, compared to its average volume of 463,291. The business’s fifty day simple moving average is $89.08 and its 200 day simple moving average is $85.61. The firm has a market cap of $5.55 billion, a P/E ratio of 24.22 and a beta of 0.75. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61. Maximus has a 1 year low of $72.39 and a 1 year high of $93.97.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Wednesday, August 7th. The health services provider reported $1.74 EPS for the quarter, topping the consensus estimate of $1.47 by $0.27. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.59% and a return on equity of 20.91%. Maximus’s quarterly revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.78 earnings per share. As a group, sell-side analysts forecast that Maximus will post 6.12 earnings per share for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were issued a $0.30 dividend. The ex-dividend date was Thursday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.30%. Maximus’s dividend payout ratio (DPR) is presently 31.50%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.